In Vivo Treatment with Antibody against IGF-1 Receptor Suppresses Growth of Human Rhabdomyosarcoma and Down-Regulates p34cdc2

作者: Thea Kalebic , Maria Tsokos , Lee J. Helman

DOI:

关键词:

摘要: In a previous study, we have shown that insulin-like growth factor type 2 (IGF-2) functions as an autocrine in human rhabdomyosarcoma (RMS) cell lines. addition, demonstrated the inhibition of binding IGF-2 to IGF-1 receptor, mediated by suramin, blocked RMS cells vitro. We now report that, vivo, specific receptor blocking antibody (alpha IR-3), but not suppresses tumor growth. Both progression tumor-bearing animals and formation newly established tumors were suppressed treatment with alpha IR-3. Histological analysis from treated did reveal necrotic lesions, implying treatments had no cytotoxic effect. The decrease was associated p34cdc2, cellular protein involved cycle regulation, suggesting resulted arrest proliferation. speculate, therefore, agents which block IGF signaling pathway may find application RMS.

参考文章(8)
M B Goldring, S R Goldring, Cytokines and cell growth control. Critical Reviews in Eukaryotic Gene Expression. ,vol. 1, pp. 301- 326 ,(1991)
Mariana Resnicoff, Michele Rubini, Raphael Rubin, Christian Sell, Renato Baserga, Domenico Coppola, Diane Ambrose, Rat Glioblastoma Cells Expressing an Antisense RNA to the Insulin-like Growth Factor-1 (IGF-1) Receptor Are Nontumorigenic and Induce Regression of Wild-Type Tumors Cancer Research. ,vol. 54, pp. 2218- 2222 ,(1994)
Pierluigi Porcu, Dorothee Wernicke, Bradford A. Jameson, Renato Baserga, Zbigniew Pietrzkowski, Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. Cancer Research. ,vol. 52, pp. 6447- 6451 ,(1992)
Quynh T. Rohlik, David Adams, Frederick C. Kull, Steven Jacobs, An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochemical and Biophysical Research Communications. ,vol. 149, pp. 276- 281 ,(1987) , 10.1016/0006-291X(87)91635-4
S H Barsky, C N Rao, J E Williams, L A Liotta, Laminin molecular domains which alter metastasis in a murine model. Journal of Clinical Investigation. ,vol. 74, pp. 843- 848 ,(1984) , 10.1172/JCI111501
Karl Riabowol, Giulio Draetta, Leonardo Brizuela, Dale Vandre, David Beach, The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells Cell. ,vol. 57, pp. 393- 401 ,(1989) , 10.1016/0092-8674(89)90914-8
R Lammers, G Carpenter, M Limardo, A Ullrich, P D Phillips, A M Soderquist, R Baserga, Z Pietrzkowski, Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth & Differentiation. ,vol. 3, pp. 199- 205 ,(1992)
C L Arteaga, L J Kitten, E B Coronado, S Jacobs, F C Kull, D C Allred, C K Osborne, Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. Journal of Clinical Investigation. ,vol. 84, pp. 1418- 1423 ,(1989) , 10.1172/JCI114315